Key Insights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

1 of 0 completed with results

Key Signals

1 with results0

4Total

P 1 (1)

P 2 (3)

Unknown2

Terminated1

Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials

Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer

Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer

Showing all 4 trials